European Commission approves the commercialization of the novel estetrol and drospirenone containing oral contraceptive
5/20/2021
Business related granted Marketing authorization application PARTNER - MITHRA PRODUCT - DROVELIS Regulatory
244 kb 5/20/2021 pdf